Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies

Background. Phase I/II studies in human immunodeficiency virus (HIV)–infected patients receiving antiretroviral therapy have shown that a single cycle of 3 weekly subcutaneous (s/c) injections of recombinant human interleukin 7 (r-hIL-7) is safe and improves immune CD4 T-cell restoration. Herein, we...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Thiébaut, Rodolphe, Jarne, Ana, Routy, Jean-Pierre, Sereti, Irini, Fischl, Margaret, Ive, Prudence, Speck, Roberto F., D'Offizi, Gianpiero, Casari, Salvatore, Commenges, Daniel, Foulkes, Sharne, Natarajan, Ven, Croughs, Thérèse, Delfraissy, Jean-François, Tambussi, Guiseppe, Levy, Yves, Lederman, Michael M.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
HIV/AIDS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4826452/
https://ncbi.nlm.nih.gov/pubmed/26908786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw065
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados